Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀Vision for Empowering Startups, Scale-Ups, and Investors
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Jul 22, 2024 3:15pm
68 Views
Post# 36143122

RE:RE:👀Vision for Empowering Startups, Scale-Ups, and Investors

RE:RE:👀Vision for Empowering Startups, Scale-Ups, and InvestorsInteresting Bart Insiders buy on the one market for one reason, they think its going up Insiders know! Bart comment on a health tech post via LinkedIn.“I love this insight. It reinforces what I always emphasize: managing expectations is crucial. Not every company that combines the buzzwords "health," "tech," "medical," "AI," and "ML" will become a unicorn. Solid market research that offers real-world evidence of a clear product-market fit, paired with a stellar team and reliable, long-term investors, will significantly enhance the likelihood of success.
https://www.linkedin.com/posts/thomas-hagemeijer_ipo-healthtech-healthcare-activity-7218918510951895040-dlrx?utm_source=share&utm_medium=member_ios

Insiders know!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities